Copyright
©The Author(s) 2024.
World J Cardiol. Aug 26, 2024; 16(8): 469-483
Published online Aug 26, 2024. doi: 10.4330/wjc.v16.i8.469
Published online Aug 26, 2024. doi: 10.4330/wjc.v16.i8.469
Table 5 Intervention characteristics of randomized controlled trials of bone-marrow-derived mesenchymal stem cells
Refs | Cell type | Cell condition | Cell source | MSCs dose and volume | Route of delivery | Concurrent procedure (if any) |
Chullikana et al[29] | BM-MSCs | Frozen | Allogenic | 2 million cells/kg, 0.5 mL/kg | IV | N/A |
Hare et al[30] | BM-MSCs | Frozen | Allogenic | 0.5, 1.6, and 5.0 × 106 | IV | N/A |
Heldman et al [34] | BM-MSCs | Fresh | Autologous | N/A | IC | PCI |
Mathiasen et al[31] | BM-MSCs | Fresh | Autologous | 77.5 ± 67.9 × 106 in 10-15 injections | IM | N/A |
Xiao et al[27] | BM-MSCs | Fresh | Autologous | 4.9 × 108 | IC | N/A |
Ulus et al[25] | BM-MSCs | Fresh | Autologous | 70 × 107 | IM | CABG |
Rodrigo et al[32] | BM-MSCs | Fresh | Autologous | 31 ± 2 × 106 IN 10-12 injections | IM | N/A |
Kim et al[16] | BM-MSCs | Fresh | Autologous | 7.2 ± 0.90 × 107 | IC | N/A |
Bolli et al[23] | BM-MSCs | Frozen | Allogenic | 1 × 108 via 20 TC injections | IM | N/A |
- Citation: Safwan M, Bourgleh MS, Aldoush M, Haider KH. Tissue-source effect on mesenchymal stem cells as living biodrugs for heart failure: Systematic review and meta-analysis. World J Cardiol 2024; 16(8): 469-483
- URL: https://www.wjgnet.com/1949-8462/full/v16/i8/469.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i8.469